LEXIVA
- Product NDC
- 49702-208
- 11-digit product format
- 497020208
- Labeler code
- 49702
- Product ID
- 49702-208_05c0714d-c373-4321-89ac-0acb18394db1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- fosamprenavir calcium
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- ViiV Healthcare Company
- Application
- NDA022116
- Marketing category
- NDA
- Marketing start
- 2010-10-04
- Marketing end
- 0000-00-00
- Substance
- FOSAMPRENAVIR CALCIUM
- Active strength
- 50 mg/mL
- Pharmacologic classes
- Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inducers [MoA], Protease Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 49702-208-53 | 49702020853 | 225 mL in 1 BOTTLE (49702-208-53) | 225 ml | 2010-10-04 | 0000-00-00 | No | No | Current |